pergolide has been researched along with Disease Exacerbation in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 5 (62.50) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cunnington, D; Dang, D | 1 |
| Bonnet, AM; Houeto, JL | 1 |
| Bergmans, P; Booij, J; Stoof, JC; van Royen, EA; Winogrodzka, A; Wolters, EC | 1 |
| Baseman, DG; Baseman, JG; Dewey, RB; Laskar, SR; O'Suilleabhain, PE; Reimold, SC | 1 |
| Bonuccelli, U; Ceravolo, R; Del Dotto, P; Gambaccini, G; Logi, C; Lucetti, C; Murri, L; Rossi, G | 1 |
| Chan, PL; Holford, NH; Kieburtz, K; Nutt, JG; Shoulson, I | 1 |
| Kellett, MW; Steiger, MJ | 1 |
| Chuda, M; Hayabara, T; Ihara, Y; Kuroda, S | 1 |
1 trial(s) available for pergolide and Disease Exacerbation
| Article | Year |
|---|---|
[Pergolide: a useful agonist for the treatment of Parkinson disease].
Topics: Antiparkinson Agents; Disease Progression; Dopamine Agonists; Dyskinesia, Drug-Induced; Electric Stimulation Therapy; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide | 2002 |
7 other study(ies) available for pergolide and Disease Exacerbation
| Article | Year |
|---|---|
Excessive daytime somnolence in spinocerebellar ataxia type 1.
Topics: Activities of Daily Living; Amantadine; Ataxin-1; Ataxins; Brain Stem; Cerebellum; Citalopram; Dextroamphetamine; Disease Progression; Disorders of Excessive Somnolence; DNA Mutational Analysis; Female; Genetic Markers; Genetic Predisposition to Disease; Genetic Testing; Humans; Middle Aged; Mutation; Naturopathy; Nerve Tissue Proteins; Nuclear Proteins; Pergolide; Polysomnography; Spinocerebellar Ataxias; Treatment Outcome | 2010 |
[(123)I]beta-CIT SPECT is a useful method for monitoring dopaminergic degeneration in early stage Parkinson's disease.
Topics: Antiparkinson Agents; Benzothiazoles; Caudate Nucleus; Cocaine; Corpus Striatum; Disease Progression; Female; Humans; Male; Nerve Degeneration; Parkinson Disease; Pergolide; Pramipexole; Putamen; Radiopharmaceuticals; Receptors, Dopamine D2; Reproducibility of Results; Thiazoles; Tomography, Emission-Computed, Single-Photon; Treatment Outcome | 2003 |
Pergolide use in Parkinson disease is associated with cardiac valve regurgitation.
Topics: Aged; Antiparkinson Agents; Aortic Valve Insufficiency; Cardiomyopathy, Restrictive; Cohort Studies; Disease Progression; Female; Heart Valve Diseases; Humans; Male; Middle Aged; Mitral Valve Insufficiency; Parkinson Disease; Pergolide; Pericarditis; Pulmonary Valve Insufficiency; Single-Blind Method; Tricuspid Valve Insufficiency; Ultrasonography | 2004 |
Long-term clinical evaluation in patients with Parkinson's disease and early autonomic involvement.
Topics: Aged; Antiparkinson Agents; Autonomic Nervous System; Bromocriptine; Disability Evaluation; Disease Progression; Dopamine Agonists; Drug Therapy, Combination; Female; Follow-Up Studies; Hemodynamics; Humans; Levodopa; Longitudinal Studies; Male; Middle Aged; Parkinson Disease; Pergolide; Prognosis; Survival Analysis | 2006 |
Disease progression and pharmacodynamics in Parkinson disease - evidence for functional protection with levodopa and other treatments.
Topics: Algorithms; Antiparkinson Agents; Bayes Theorem; Bromocriptine; Disease Progression; Dopamine Agonists; Drug Therapy, Combination; Humans; Levodopa; Models, Biological; Parkinson Disease; Pergolide; Randomized Controlled Trials as Topic; Selegiline; Treatment Outcome | 2006 |
Deterioration in parkinsonism with low-dose pergolide.
Topics: Adult; Aged; Antiparkinson Agents; Disease Progression; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Male; Parkinson Disease; Pergolide; Receptors, Dopamine | 1999 |
Hydroxyl radical and superoxide dismutase in blood of patients with Parkinson's disease: relationship to clinical data.
Topics: Age Factors; Age of Onset; Aged; Antiparkinson Agents; Bromocriptine; Disease Progression; Erythrocytes; Humans; Hydroxyl Radical; Levodopa; Middle Aged; Multiple System Atrophy; Parkinson Disease; Pergolide; Severity of Illness Index; Statistics as Topic; Superoxide Dismutase; Time Factors | 1999 |